CADTH & Advisory Panel for a Pan-Canadian Prescription Drug List - CADTH was chosen to establish the Advisory Panel to develop a framework for a pan-Canadian prescription drug list. CADTH will provide this service to Health Canada due to its relationship with federal, provincial, and territorial jurisdictions and other healthcare stakeholders on top of its [...]
Only One Submission at the EU level! The joint clinical assessment of new health technologies is a valuable step to accelerate patients' access to new health technologies, manufacturers' access to the market and increase the efficiency of national HTA bodies' assessments to make informed pricing and reimbursement decisions. The value of this joint work on [...]
Artificial Intelligence in the Regulatory Processes - Artificial intelligence can accelerate the drug development process and reduce its cost by virtual screening new molecules and optimizing patient recruitment in trials. Artificial intelligence can accelerate the drug development process and reduce its cost by virtual screening new molecules and optimizing patient recruitment in trials. According to [...]
Artificial Intelligence in Outcomes Research - Quality HTA is pleased to announce its recent paper “Artificial Intelligence in Outcomes Research: A Systematic Scoping Review” published online by the Expert Review of Pharmacoeconomics & Outcomes Research journal. This study aims to systematically capture the scope of artificial intelligence methods used in outcomes research studies to enhance [...]
CADTH Symposium Presentations - On-demand presentations including "Artificial Intelligence in Outcomes Research: A Systematic Review to Inform Decision Makers" are available for registrants in the "All sessions" tab on the CADTH Symposium website. These presentations will be available from today November 24th, 2020 to March 21st, 2021.
CADTH Symposium 2020 Quality HTA is pleased to announce the presentation of "Artificial Intelligence in Outcomes Research: A Systematic Review to Inform Decision Makers" at the CADTH (virtual) Symposium on November 9th and 10th, 2020. This post will be updated as soon as the on-demand presentations would be available on the Symposium website. [...]
SMDM Congress Quality HTA is pleased to announce the presentation of "Artificial Intelligence in Outcomes Research Studies" at SMDM (virtual) Congress 2020. This pre-recorded presentation would be available for registrants on the four Tuesdays of October.
A Portable Antigen Test for COVID-19 Portable, fast, cheap, sensitivity of 97.1% and specificity of 98.5%, with a mobile app for Android and iPhone. A great option for indoor public places and going back to our previous daily life! Ref: Financial Post
INAHTA Database A great free platform to search over 16,000 ongoing and completed HTA records from 120 HTA producers across the world for those who have experienced the challenges of the CRD database! Useful for governments, the life-science industry, researchers and consultants. https://www.inahta.org/hta-database/
PMPRB News The PMPRB regulation was supposed to be implemented on July 1st, 2020 but has been postponed to Jan 1st, 2021 and a new draft is supposed to be published on the week of June 15, 2020. (Ref.) Six months delay in implementation of PMPRB new regulations. Is it because of COVID-19, the feedbacks [...]